Innovation as a Service

Recent launch

A mechanical elbow brace that steadies tremors in the dominant arm, so people with movement disorders — children and adults — can get through daily activities. It started as one neurologist’s frustration and ended in an FDA registration and an exit.

The pain point. A pediatric neurologist and his patient named the gap.
Validation. We ran a market assessment through the Lab’s clinical network. Patients, clinicians, and caregivers confirmed the need.
Build. QMS-compliant engineering and a published clinical study turned the concept into a clinically validated MVP.
Market. FDA registration, limited launch in 2024, a reimbursement recommendation from AOPA, and a same-year exit to OrthoPediatrics.

A child writing at a desk while wearing the Move-D elbow brace

The Move-D mechanical elbow brace components

How it works

Two phases, with a decision point in between.

Phase 1 answers whether the opportunity is real. Phase 2 lays out the path from idea to product in market. You decide at the end of Phase 1 whether there’s a Phase 2 — and you can commission Phase 2 whole or one project at a time.

Phase 1

Product opportunity assessment

“Is there a market signal here?”

8–10 WEEKS

A clinical, operational, and commercial read on whether a new product is viable.

Customer and user discovery. Interviews with the clinicians and procedural staff living with the problem today — how bad the pain point is, what it costs, where it breaks workflow, what it means for patient safety.
Perceived value. What clinicians and subject matter experts say the solution is actually worth to them, clinically and operationally.
Industry outreach. Direct conversations with medical device companies in the space: do they see the problem, how are they solving it now, would they partner on a new approach.
Competitive and IP scan. Existing devices and manual workarounds, and where your idea sits against them.

Ends with a findings presentation and a joint call on what happens next.

Phase 2

Execution

“How do we get it to market?”

24–30 WEEKS

A roadmap for building the device and bringing it to market, in five parts:

IP landscape — Is this novel enough to patent?
Market definition — Is the market big enough? Target segments, plus addressable market in the U.S. and globally.
Competitive landscape — Is it differentiated enough to drive adoption? A competitor matrix and a straight answer on where you stand apart.
Development plan and risks — How does it get built, and what could go wrong? Development and commercial risk, regulatory and reimbursement, other barriers to entry.
Business model — How does it reach the market? Go-to-market pathway, named commercial partners worth targeting, and a financial model covering revenue, COGS, and total cost to regulatory approval.

Ends with a full findings summary and an executive presentation.

Pricing

Priced by scope, not by hour.

Take Phase 2 as a bundle or commission the projects separately.

Scope	Cost	Timeframe
Phase 1 Is there a market signal here?	$24,000	8–10 weeks
Phase 2 bundle All three projects below	$60,000	24–30 weeks
IP landscape assessment	$5,000	4–6 weeks
Market definition + competitive landscape	$20,000	10–12 weeks
Commercialization plan, risks, and business model	$42,000	14–16 weeks

The commercialization project runs only after the first two are complete.

Evaluate, develop, and commercialize your medical device ideas.

Two phases, with a decision point in between.

Product opportunity assessment

Execution

Priced by scope, not by hour.

Clinical, design, and commercial people in the same room.

Tell us what you’re trying to solve.

Start a conversation